Xiaohong Xu

Dr. Xiaohong Xu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2017 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
QHQing-Wen He
Qing-Wen He
XXXiaohong Xu
Xiaohong Xu
FLFang-Jun Lan
Fang-Jun Lan
ZZZhi-Chang Zhao
Zhi-Chang Zhao
ZWZhi-Yun Wu
Zhi-Yun Wu
BLBin Li
Bin Li
Colistin has been considered as a last-line treatment option in severe infections caused by multidrug-resistant (MDR) gram-negative pathogens. However, the emergence of the mobile colistin resistance gene (mcr-1) has challenged this viewpoint. The aim of this study is to explore the prevalence of mcr-1 in Escherichia coli (E. coli) in a Chinese teaching hospital, and investigate their molecular characteristics. A total of 700 E. coli isolates were used to screen mcr-1 by PCR and sequencing in a Chinese university hospital from August 2014 to August 2015. Susceptibility test of mcr-1-producing isolates was determined by Vitek -2 Compact system. 26 virulence factors (VFs), phylogenetic groups, Multi-locus sequence typing (MLST), and DNA Fingerprinting (ERIC-PCR) of strains were investigated by PCR. Four (0.6%) mcr-1 producing E. coli isolates were found in this study. The results of antibiotic susceptibility test showed that all four isolates were resistant to colistin, ciprofloxacin, levofloxacin, cefazolin, and trimethoprim/sulfamethoxazole, and were susceptible to amikacin, ertapenem and imipenem. In addition, all 4 isolates exhibited high-level resistance to aztreonam, cefotaxime and gentamicin. The numbers of VFs contained in mcr-1 positive isolates were no more than 4 in our study. MLST result demonstrated that these isolates were assigned to two sequence types: ST156 and ST167. The result of phylogenetic analysis showed that four mcr-1-positive isolates belong to two phylogenetic groups: A and B1 group. ERIC-PCR showed that four mcr-1 positive strains were categorized into three different genotypes. Our study demonstrated a low prevalence of mcr-1 in E. coli clinical isolates in a Chinese teaching hospital, and we have gained insights into the molecular characteristics of these mcr-1-positive strains. Increasing the surveillance of these infections, as well as taking effective infection control measures are urgently needed to take to control the transmission of mcr-1 gene.

28 September 2024 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
SLSiyan Lian
Siyan Lian
CLChang Liu
Chang Liu
MCMeili Cai
Meili Cai
YCYingping Cao
Yingping Cao
XXXiaohong Xu
Xiaohong Xu
There is a serious public health concern regarding the emergence of carbapenem-resistant Escherichia coli (CREC). The purpose of this study is to identify the molecular characterization and risk factors of CREC in Fujian province, China. A total of 48 CREC isolates were collected from various clinical samples. The strains were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS). Susceptibility to antibiotics was determined by the standard broth microdilution method. Polymerase chain reaction (PCR) was used to screen common drug resistance genes. Multilocus sequence typing (MLST) was used to type isolates. RT-qPCR was used to detect gene expression of acrA, acrB, and tolC. Conjugation assays were used to analyze the transferability of plasmids carrying mcr-1 or blaNDM. Risk factors for CREC infection were identified by logistic regression analysis. 48 CREC strains were collected, with 81.25% producing carbapenemase (CP-CREC), and 18.75% were not producing carbapenemase (no-CP-CREC). They belonged to 21 sequence type (STs) and five unknown STs. Perianal swabs were the main sample type, with 25 patients found to have hematological malignancies. All isolates of CP-CREC were found to contain blaNDM (blaNDM−5 (n = 32), blaNDM−1 (n = 5), blaNDM−4 (n = 1), and blaNDM−13 (n = 1)), among which one isolate co-existence blaNDM−5 and blaOXA−48. Two blaNDM-positive strains, specifically blaNDM−5 and blaNDM−4, were found to co-habor mcr-1 with ST617. Conjugation assays confirmed that blaNDM−1, blaNDM−13, and most blaNDM−5(68.75%, 22/32) could be transferred between E. coli strains. Four of the 9 non-CP-CREC isolates had deletions in ompC and ompF with blaCTX−M production, while the other five showed high expression of acrA, acrB, and tolC. Antibiotics usage, antifungal treatment, detection of other pathogens (prior to CREC infection), and respiratory disease were identified as independent risk factors for CREC infection. The area under the receiver operating characteristic curve for the scoring system was 0.937. Youden’s index, with sensitivity and specificity of 0.96 and 0.78, was maximal when 2 points were scored. In CP-CREC, carbapenem resistance is caused primarily by multiple types of blaNDM, while non-CP-CREC is caused by loss of porin protein or high expression of efflux pumps coupled with carrying blaCTX−M. CREC isolates were highly diverse in terms of ST, with a total of 21 STs identified. Here, we first describe a clinical strain of CREC from China both mcr-1 and blaNDM −4 with ST617. An easy-to-use scoring system was developed to diagnose CREC infections.

24 November 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
SYShu Yang
Shu Yang
LZLaiyu Zou
Laiyu Zou
HLHuixin Liang
Huixin Liang
XXXiaohong Xu
Xiaohong Xu
XCXiaoling Chen
Xiaoling Chen
Background: Early and accurate identification of Escherichia coli ( E. coli ) infection in intensive care unit (ICU) patients remains challenging butmay improve clinical outcomes if addressed effectively. This study aimed to develop and validate an interpretable machine learning model for early prediction of E. coli infection at ICU admission. Methods: This retrospective study was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Adult patients (aged 18–100 years) with their first ICU admission and a length of stay ≥24 hours were included. E. coli infection was identified based on microbiological results and diagnostic codes. Missing data were imputed using the missForest algorithm. Feature selection was performed with Boruta and least absolute shrinkage and selection operator (LASSO), and intersecting variables were used for model construction. Eight machine learning models, logistic regression, k-nearest neighbors, decision tree, random forest, extreme gradient boosting, light gradient boosting machine, support vector machine (SVM), and neural network, were developed. Model performance in the validation cohort was assessed using area under the receiver operating characteristic curve (AUC) with 95% confidence interval (CI), sensitivity, specificity, F1 score, calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC). Model interpretability was evaluated with Shapley additive explanations (SHAP). Results: A total of 52, 554 ICU patients were analyzed, of whom 4, 157 (7.9%) had E. coli infection. Twenty-eight intersecting variables were selected for modeling. Among all models, the SVM achieved the highest discrimination (AUC = 0.745, 95% CI: 0.726-0.764), followed by random forest (AUC = 0.742) and extreme gradient boosting (AUC = 0.739). Calibration and decision analyses indicated robust model calibration and clinical utility. SHAP analysis identified gender, age, sepsis, sedative use, and potassium level as the most influential predictors. A web-based tool was developed to enable real-time clinical risk estimation and individualized interpretability. Conclusions: An interpretable SVM-based machine learning model was developed and validated for early prediction of E. coli infection in ICU patients, demonstrating good discrimination, calibration, and potential clinical benefit. The associated online tool provides transparent, individualized risk predictions and may facilitate timely clinical decision-making.

26 August 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
XLXuyang Li
Xuyang Li
PGPengfei Gao
Pengfei Gao
MCMeiyun Chen
Meiyun Chen
BLBin Li
Bin Li
XXXiaohong Xu
Xiaohong Xu
This study evaluated Eravacycline (ERV)’s effectiveness against carbapenem-resistant gram-negative bacteria (CRGNB) and identified risk factors for ERV non-susceptible Klebsiella pneumoniae (ENSKP) infections to support clinical treatment and early detection. Between 2021 and 2024, 235 Carbapenem-Resistant Acinetobacter baumannii(CRAB) strains, 48 Carbapenem-Resistant Escherichia coli (CRECO) strains, and 158 Klebsiella pneumoniae (KP) strains were collected. Resistance genes were identified using PCR, and the minimum inhibitory concentration of tigecycline and ERV was determined using the broth microdilution method. Susceptibility was assessed according to U.S. Food and Drug Administration (FDA) and EUCAST breakpoints, and logistic regression identified ENSKP infection risk factors. For CRAB, ERV’s MIC50 and MIC90 were 0.5 µg/ml and 1 µg/ml, while tigecycline’s were 2 µg/ml and 4 µg/ml. For Carbapenem-Resistant Klebsiella pneumoniae (CRKP), ERV’s MIC50 and MIC90 were 0.5 µg/ml and 2 µg/ml, and tigecycline’s were 2 µg/ml and 4 µg/ml. For CRECO, both ERV and tigecycline had MIC50 and MIC90 of 0.25 µg/ml and 0.5 µg/ml. The study found 25 KP strains non-susceptible to ERV, with no prior ERV treatment. The ENSKP group had higher ECOG scores, more invasive procedures, more antibacterial drug use, and longer hospital stays compared to the ERV susceptible KP. Our study demonstrated that ERV effectively combats CRGNB, providing a potential basis for future treatment of drug-resistant infections. ENSKP infection can occur without ERV use. Effective surveillance and antibiotic stewardship are essential for managing ENSKP in high-risk patients.

1 January 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
RZRongping Zhu
Rongping Zhu
JLJu Li
Ju Li
SLSiyan Lian
Siyan Lian
YLYishan Li
Yishan Li
MCMeili Cai
Meili Cai
XXXiaohong Xu
Xiaohong Xu
Background: Therefore, the objectives of this study were to investigate the prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) in Fujian Medical University Union Hospital, identify their genetic characters, characterize their resistance profiles, and identify risk factors for their infection to improve prevention and treatment strategies for CR-hvKp in the area. Methods: Between January 2021 and January 2022, clinically identified carbapenem-resistant Klebsiella pneumoniae (CRKp) isolates were collected. A PCR assay was used to detect the K capsule type, virulence genes, carbapenemase genes, and membrane pore protein. ERIC-PCR was carried out for homology analysis. Antimicrobial susceptibility test was used to determine drug resistance. Logistic multivariate regression analysis was conducted to confirm the risk factors for CR-hvKp infection. Results: In total, 239 CRKp isolates were obtained. The virulence genes with the highest detection rates were mrkD, iucA, and rmpA2. Of these isolates, 54 (22.59%) carried both iucA and rmpA2, thus classifying them as CR-hvKp. All CR-hvKp isolates carried blaKPC. Furthermore, capsular serotypes K64 (94.44%) and K47 (3.70%) were detected. Resistance was observed against most common antibiotics, with the exception of complete sensitivity to ceftazidime-avibactam. ERIC-PCR indicated a potential clonal spread among CR-hvKp. Multivariate analysis found that changing beds was a risk factor for CR-hvKp infection. Conclusion: Currently, the hospital predominantly carries K64 CR-hvKp that harbors the blaKPC. Our study found that changing patient beds was an independent risk factor for CR-hvKp infection.

26 November 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
QZQingzhu Zheng
Qingzhu Zheng
SCSiyan Chen
Siyan Chen
JWJiamiao Weng
Jiamiao Weng
HHHuaxiang Huang
Huaxiang Huang
XXXiaohong Xu
Xiaohong Xu
YCYingping Cao
Yingping Cao
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies within the digestive system, characterized by alarmingly high incidence and mortal